 She has received honorary appointments as an associate faculty member at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland and adjunct professor at Tufts University School of Medicine in Boston, Massachusetts.Kang played a significant role in the efforts that culminated in the development of Rotavac, a vaccine from Bharat Biotech International that targets diarrhea.She was one of three principal investigators in the Phase III clinical trials of the vaccine.